Lataa...
Understanding the outcomes measures used in Huntington disease pharmacologicaltrials: A systematic review
BACKGROUND: The identification of the gene mutation causing Huntington disease has raised hopes for new treatments to ease symptoms and slow functional decline. As such, there has been a push towards designing efficient pharmacological trials (i.e., drug trials), especially with regard to selecting...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217648/ https://ncbi.nlm.nih.gov/pubmed/25300328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-140115 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|